Main menu

Diagnosing the undiagnosed with long-read genome data


In this talk, Wendy Chung shares how her team at Boston Children's Hospital are using Oxford Nanopore sequencing to help uncover answers in unsolved, short-read negative rare disease cases.

See our blog article for more on how Dr Chung and others are demonstrating the potential of nanopore sequencing to reshape rare disease diagnosis in the future.

Wendy Chung, M.D., Ph.D., is a clinical and molecular geneticist and the Chief of the Department of Pediatrics at Boston Children’s Hospital and the Mary Ellen Avery Professor of Pediatrics at Harvard Medical School.

Please note: This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.

Authors: Wendy Chung, Chief of the Department of Pediatrics at Boston Children's Hospital

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag